about
Exon/intron organization of the genes coding for the delta chains of the human and murine T-cell receptor/T3 complexPathogenesis of human immunodeficiency virus infectionHuman immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin AInhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin AApoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1Mechanistic aspects of HIV-1 reverse transcription initiation.Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro.Prospects for an HIV vaccine: conventional approaches and DNA immunization.Human T-cell lymphotropic virus type III shares sequence homology with a family of pathogenic lentiviruses.Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys).Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells.Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication.Molecular mechanisms of HIV latency.Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate.Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1.Persistent human immunodeficiency virus type 1 infection of monoblastoid cells leads to accumulation of self-integrated viral DNA and to production of defective virions.Human immunodeficiency virus infection of monoblastoid cells: cellular differentiation determines the pattern of virus replicationIsolation and characterization of simian immunodeficiency virus from mandrills in Africa and its relationship to other human and simian immunodeficiency viruses.Genomic diversity of the acquired immunodeficiency syndrome retroviruses is reflected in alteration of its translational products.Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus.Genetic variability in human immunodeficiency viruses.Animal models for retrovirus-induced immunodeficiency disease.Equine infectious anemia virus and human immunodeficiency virus DNA synthesis in vitro: characterization of the endogenous reverse transcriptase reaction.Recombinant polypeptide from the endonuclease region of the acquired immune deficiency syndrome retrovirus polymerase (pol) gene detects serum antibodies in most infected individuals.Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24.Expression of envelope glycoproteins of human immunodeficiency virus by an insect virus vector.Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay.Analogie entre les rétrovirus humains lymphotropes et les rétrovirus des grands animaux.Analogy between lymphotropic human retroviruses and large animal retroviruses.Cystatins in health and disease.An Hsp60 related protein is associated with purified HIV and SIV.Expression of RNA and antigens of human immunodeficiency virus type-1 (HIV-1) in lymph nodes from HIV-1 infected individuals.
P2860
Q24630784-0E88403C-26CE-47E0-A405-B6DBD5BB7DF7Q24634681-D986DFF0-A95E-4C4F-81A3-56348C2F5127Q24649411-05D39877-D2E2-41E5-AC75-833EC6A79C6BQ28368142-536D4429-EE8A-4B94-8F8A-390009D8CB87Q34188750-ACF70100-6A72-4B75-82C0-C55E23A50512Q34490256-035DA11A-5509-4477-B323-E3F5C20E74A3Q34619968-FE83FF38-0535-4F65-9C56-A7C9435A5CA3Q35042496-788F8A7E-05A8-44D7-9E76-F504E3896AB0Q35609332-340E1201-B922-4DD1-B7ED-FD496F7B118FQ35617653-843D88DE-F03A-4DCA-A96A-6C38D65F7B1AQ36009232-476989AA-17D6-47A9-B7C4-4943B0E893EEQ36353585-AA1BC75F-F9FC-49C8-B4C4-71745DB47383Q36355743-057053F9-ACFF-4B6E-8EF7-2449B32A8D95Q36515063-7E948CCF-9806-4BDB-A88A-183BA4116CAFQ36629169-13BB7DB7-ADA1-4766-AA0C-1AA6EC5206B2Q36684585-AAE0E9CF-AC00-47CF-8B07-A205822AC3E6Q36830283-9E0A871C-443B-4AF2-BABE-F90DB80C3103Q36872826-ECF8FD3F-EB88-44A6-9EBC-1A26DFF2866CQ36881478-B94C6385-DCFB-46C0-B969-79DF5B8D68D4Q37393289-38ECC6E5-FAA8-4BDA-8325-687DB2877440Q37546388-57B8FFF9-F193-4209-AA3D-A0BA61260840Q38869338-75999FFB-2246-4A3B-A4A0-F4DDB3F9EFCDQ39504788-5713498D-38C1-4754-A239-9D764336ED7FQ40060086-EF169180-4316-480B-92D4-CAFEBB64F9A8Q40126134-66C9B402-445B-4A9F-B346-D4EE6C5C92D1Q40136156-5FA1A50F-19AA-48AA-B165-548A49CC750CQ40141196-458C4F94-429E-4D8C-8F35-CA344FA77C5DQ40191379-DA88E0F2-5C32-4129-B011-5A389C724ED6Q40468086-902645E0-7702-4626-8186-BB8C01AACC3EQ40470626-84911D43-469B-4452-B47E-03C8D3B90DF9Q41161690-66029E22-00B7-449B-A978-EF127A98375CQ41491977-4F60181F-ABDC-40DB-B254-7C18519EADD1Q41890654-7D533BEB-CC08-46E7-A057-446B97148523
P2860
description
1984 nî lūn-bûn
@nan
1984 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Molecular cloning of lymphadenopathy-associated virus.
@ast
Molecular cloning of lymphadenopathy-associated virus.
@en
Molecular cloning of lymphadenopathy-associated virus.
@nl
type
label
Molecular cloning of lymphadenopathy-associated virus.
@ast
Molecular cloning of lymphadenopathy-associated virus.
@en
Molecular cloning of lymphadenopathy-associated virus.
@nl
prefLabel
Molecular cloning of lymphadenopathy-associated virus.
@ast
Molecular cloning of lymphadenopathy-associated virus.
@en
Molecular cloning of lymphadenopathy-associated virus.
@nl
P2093
P50
P356
P1433
P1476
Molecular cloning of lymphadenopathy-associated virus.
@en
P2093
Tiollais P
Wain-Hobson S
P2888
P304
P356
10.1038/312757A0
P407
P577
1984-12-01T00:00:00Z
P6179
1027090356